Chloroquine is effective against influenza A virus in vitro but not in vivo
Open Access
- 1 September 2007
- journal article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 1 (5-6) , 189-192
- https://doi.org/10.1111/j.1750-2659.2007.00027.x
Abstract
Background Chloroquine is an inexpensive and widely available 9-aminoquinolone used in the management of malaria. Recently, in vitro assays suggest that chloroquine may have utility in the treatment of several viral infections including influenza. Objectives We sought to test whether chloroquine is effective against influenza in vivo in relevant animal models. Methods The effectiveness of chloroquine at preventing or ameliorating influenza following viral challenge was assessed in established mouse and ferret disease models. Results Although active against influenza viruses in vitro, chloroquine did not prevent the weight loss associated with influenza virus infection in mice after challenge with viruses expressing an H1 or H3 hemagglutinin protein. Similarly, clinical signs and viral replication in the nose of ferrets were not altered by treatment. Conclusions Although in vitro results were promising, chloroquine was not effective as preventive therapy in vivo in standard mouse and ferret models of influenza virus infection. This dampens enthusiasm for the potential utility of the drug for humans with influenza.Keywords
This publication has 16 references indexed in Scilit:
- Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A virusesVirology Journal, 2007
- Live Attenuated Influenza Vaccine Is Safe and Immunogenic in Immunocompromised FerretsThe Journal of Infectious Diseases, 2006
- In vitro inhibition of human influenza A virus replication by chloroquineVirology Journal, 2006
- Isolation of drug-resistant H5N1 virusNature, 2005
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) ActivityCurrent Pharmaceutical Design, 2004
- Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine releaseInternational Immunopharmacology, 2004
- Preventing and treating influenzaBMJ, 2003
- Eight-plasmid system for rapid generation of influenza virus vaccinesVaccine, 2002